CRISPR Therapeutics names Siva Sakhamuri chief technical officer
CRSP•CRISPR Therapeutics appointed Sivakesava (Siva) Sakhamuri chief technical officer, effective immediately; he joins from Orna Therapeutics with about 30 years of manufacturing leadership experience.
1. Leadership appointment
Sakhamuri served as chief technical officer at Orna Therapeutics since 2024 before joining CRISPR Therapeutics.




